@article{d0f5741f942141388deae151ed21b564,
title = "Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions",
abstract = "PURPOSE OF REVIEW: After three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches.RECENT FINDINGS: Several promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations.SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.",
keywords = "BIPOLAR DEPRESSION, DEEP TMS, DOUBLE-BLIND, EFFICACY, MAJOR DEPRESSION, METAANALYSIS, NETWORK, RTMS, TMS TREATMENT, TREATMENT-RESISTANT DEPRESSION, depression, efficacy, repetitive transcranial magnetic stimulation",
author = "Baeken Chris and Anna-Katharine Brem and Martijn Arns and Brunoni, {Andre R} and Igor Filip{\v c}i{\'c} and Ganho-{\'A}vila Ana and Berthold Langguth and Frank Padberg and Emmanuel Poulet and Fady Rachid and Sack, {Alexander T} and Marie-Anne Vanderhasselt and Djamila Bennabi",
note = "Funding Information: The Center for Research in Neuropsychology and Cognitive Behavioral Intervention of the Faculty of Psychology and Educational Sciences of the University of Coimbra is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013]. This work was also supported by the German Center for Brain Stimulation (GCBS) research consortium (grant number 01EE1403), funded by the Federal Ministry of Education and Research (BMBF). Funding Information: C.B., F.P., and E.P. are members of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel. F.P.{\textquoteright}s lab has received support with equipment from neuroConn GmbH, Ilmenau, Germany, and Mag&-More GmbH and Brainsway Inc., Jerusalem, Israel. Research Institute Brainclinics received research funding from Brain Resource (Sydney, Australia) and neuroCare Group (Munich, Germany), and equipment support from Deymed, neuroConn, and Magventure. Publisher Copyright: {\textcopyright} 2019 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2019",
month = sep,
doi = "10.1097/YCO.0000000000000533",
language = "English",
volume = "32",
pages = "409–415",
journal = "Current Opinion in Psychiatry",
issn = "0951-7367",
publisher = "LIPPINCOTT WILLIAMS & WILKINS",
number = "5",
}